A calm modern hospital interior — pale stone walls, light wood acoustic panels, soft daylight.
Cost guide · 2026-06-21

Cataract Surgery in China: Three Structural Reasons It Costs Less

International patients hunting for cataract or refractive lens exchange (RLE) keep finding the same gap: long waits at home, four-figure quotes in the local private sector, and very little visibility into what they are paying for. China keeps coming up in those searches for a reason. The headline price is lower, but that is the symptom. The price is lower because the cost stack itself is built differently. Three things drive it.

1. The lens is procured at national scale

In most countries, the intraocular lens (IOL) sits inside a bundled private quote. Nobody sees it. Patients are quoted a single number, and the lens cost is hidden somewhere inside the package. China publishes it.

The national volume-based procurement (VBP) round for IOLs lists winning prices by lens category. Standard aspheric monofocal lenses came in at CNY 628–1,034. EDOF non-toric lenses at CNY 3,596–6,990. Trifocal toric lenses at CNY 12,996–18,188.[1] These are not promotional numbers. They are central procurement results, public on the regulator's website.

This matters in two ways. The lens layer is cheaper, because aggregated national demand wins better unit prices. And the lens layer is visible, because procurement results are open. Hospitals quote against a published reference, not a black box.

A private quote in London, Dublin, or Sydney does not work like that. The lens is one of the most expensive single components, and the patient never sees its cost separately. China's approach removes one of the largest opaque mark-ups in cataract and RLE pricing.[2]

2. The workforce is built for scale, not for boutique pricing

Cataract care is staff-heavy. Biometry. Retinal screening. Lens counselling. Consent. Translation. Discharge. Follow-up. Every step before and after the operating room needs people.

China treats eye health as a public-health capacity issue. The National Health Commission's 14th Five-Year National Eye Health Plan set a 2025 cataract surgical-rate target above 3,500 operations per million people.[3] Hitting that target requires a workforce that already exists.

It does. A 2024 nationwide survey counted 48,652 ophthalmologists, 64,495 ophthalmic nurses, and 14,320 optometrists in mainland China.[4] Top-tier eye hospitals in Shanghai and Wenzhou run high-throughput cataract and refractive programmes built around that staffing base.

A workforce trained and funded at this scale changes what a clinic can offer. Bundled patient pathways, in-house lens counselling, interpreter support, and structured aftercare stop being premium add-ons. They become standard service. The cost per patient drops because the system is designed for many patients, not for a few high-margin ones.

3. Volume compounds into skill

Cataract surgery is the most common operation in the world. Teams that perform it constantly standardise everything: pre-op measurement, theatre flow, sterilisation, lens selection, discharge checks, complication response.

China's volume curve is steep. Cataract surgical rates rose from 1,200 to 2,205 operations per million people between 2013 and 2017, with the 2025 policy target above 3,500.[5] The leading hospitals sit far above the national average.

Volume alone is not safety. The peer-reviewed evidence is more useful: a Scientific Reports analysis of Chinese small- and medium-scale ophthalmology departments found acute postoperative endophthalmitis in 0.11% of 46,185 cataract operations. Departments doing fewer than 500 cases a year had higher odds.[6]

The implication is concrete. High-volume Chinese centres are where the practised hands work. That is the layer worth selecting for — not lowest sticker price.

What MediConnex does

MediConnex is built for international patients who want to know what they are actually buying. We compare your local public wait, your local private quote, and a vetted China pathway in one free review.

We do not sell surgery. We sell clarity: which lens category, which hospital, what is included in the quote, what the realistic timeline looks like, and what happens if surgery is not the right call after assessment.

If the China pathway makes sense for your case, we coordinate the rest — translation, records review, hospital booking, travel, and aftercare.

Free 10-minute review
Wait-time and eligibility check
Plain comparison of your local public wait, your local private quote, and a vetted China pathway — no obligation.
WhatsApp +44 7304 350684 Email info@mediconnex.com.cn

This article is general patient information, not a clinical recommendation. Cataract and RLE outcomes depend on individual clinical assessment. MediConnex is a navigation and coordination service, not a clinical decision-maker. Suitability, lens choice, retinal and refractive status, expectations, and aftercare access matter as much as price. See our medical disclaimer for the full position.

Sources